| Cat.No. | Name | Information |
|---|---|---|
| M66257 | Anti-Mouse CD93/C1qR Antibody (Clone Fs0409) | Anti-Mouse CD93/C1qR Antibody (Clone Fs0409) is a monoclonal antibody targeting mouse CD93 (also known as C1q receptor). |
| M66209 | Anti-TfR Reference Antibody | Anti-TfR Reference Antibody (Jr-141) is a humanized anti-human transferrin receptor (CD71; TfR) antibody. |
| M65746 | Greziprubart | Greziprubart is an C5a-targeting IgG1κ type human monoclonal antibody. |
| M65735 | Anti-Mouse IL-13 Antibody (Clone ID: BAK209B11) | Anti-Mouse IL-13 Antibody is an anti-mouse IL-13 IgG2a monoclonal antibody. |
| M65712 | Recombinant Anti-mouse PD-1 mAb (Clone RMP1-14) InVivo | |
| M59290 | Clivatuzumab | Clivatuzumab is a humanized anti-mucin monoclonal antibody targeting an epitope in the MUC1 antigen expressed in most pancreatic cancers. |
| M59289 | U3-1784 | U3-1784 is a humanized antibody that targets FGFR4/CD334. U3-1784 is equipped with a huIgG1 heavy chain and a huλ light chain. |
| M59270 | Coltuximab | Coltuximab is a humanized antibody that targets CD19. Coltuximab is composed of huIgG1 heavy chains and huκ light chains, with a predicted molecular weight (MW) of 145 kDa. |
| M59213 | Etalanetug | Etalanetug (E2814) is a humanized high-affinity IgG1 antibody that targets tau protein (MAPT) and can cross the blood-brain barrier. Etalanetug inhibits the spread of pathological tau protein through high-affinity binding to the microtubule-binding region (MTBR). |
| M59211 | Peresolimab | Peresolimab is a humanized IgG1-κ antibody targeting to PD-1. Peresolimab potentially stimulates physiological immune inhibitory pathways to restore immune homeostasis. |
| M59182 | Anzurstobart | Anzurstobart (CC-95251; BMS-986351) is a high-affinity, fully human monoclonal anti-SIRPα antibody that blocks the binding of CD47 to SIRPα. Anzurstobart enhances macrophage phagocytic activity against DLBCL cell lines in co-culture models when combined with the antibody Rituximab. |
| M59172 | PF-03732010 (CHO) | PF-03732010 is a humanized antibody targeting CDH3/P-cadherin. |
| M59147 | Ecromeximab | Ecromeximab (KM 871; KW 2871) is an IgG-κ chimeric antibody targeting ganglioside GD3. |
| M59069 | Depatuxizumab | Depatuxizumab is a brain-penetrant and humanized tumor-specific anti EGFR monoclonal antibody. Depatuxizumab inhibits the growth of xenograft models of mutant EGFRvIII and wild-type EGFR. |
| M59065 | Lifastuzumab | Lifastuzumab is a humanized anti-NaPi2b IgG1 monoclonal antibody. |
| M58975 | ADCT-901 | |
| M58698 | Anti-Mouse CD40 Antibody (Clone FGK45) In vivo | CD40 is a 48 kD type I transmembrane glycoprotein that is a member of the TNFR superfamily. CD40 interacts with TNFR2 and is involved in the regulation of signal transduction. CD40 is a potential target for cancer immunotherapy. CD40 is widely expressed on antigen-presenting cells such as dendritic cells, B cells, macrophages, and monocytes, in addition to non-immune endothelial cells, basal epithelial cells, and a variety of tumors. Clone FGK45 recognizes an epitope on mouse CD40. |
| M58555 | Volociximab | Volociximab (M200) is a chimeric human/murine IgG4 antibody IIA1 targeting integrin α5β1 (EC50=0.2 nM). Volociximab has antiangiogenic and antitumor activities and inhibits the proliferation of human umbilical vein vascular endothelial cells (HUVECs). |
| M58432 | Anti-Mouse RANKL/CD254 Antibody (Clone 7C6) In vivo | Anti-Mouse RANKL/CD254 Antibody (Clone 7C6) is a Mouse-derived VHH-mFc type antibody, targeting to mouse RANKL/CD254. |
| M58370 | Gemtuzumab | Gemtuzumab is a monoclonal IgG4-κ antibody targeting CD33 antigen, which present on leukemic myeloblasts of acute myeloid leukemia (AML). Gemtuzumab can be used for the synthesis of antibody-drug conjugate (ADC) Gemtuzumab ozogamicin. |
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2026 AbMole BioScience. All Rights Reserved.
